Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 52 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of April 18, 2024 is 48.30.
  • The all-time high Bristol Myers Squibb stock closing price was 75.88 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 70.94, which is 46.9% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 47.58, which is 1.5% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 56.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 50.2999 51.5568 53.7723 47.4264 48.3000 -3.67%
2023 60.1323 67.5873 70.2630 47.3744 50.1399 -25.49%
2022 67.3774 56.1253 75.8837 56.1253 67.2973 19.00%
2021 56.4633 54.3889 62.3480 48.6425 56.5516 2.89%
2020 52.7239 54.4092 57.9225 39.8577 54.9649 0.39%
2019 42.2802 43.1902 54.7503 36.1809 54.7503 27.86%
2018 47.1048 49.1907 55.7031 40.1670 42.8195 -12.91%
2017 45.7429 46.4331 52.4321 36.8097 49.1667 7.72%
2016 48.8882 51.4156 59.5478 38.4508 45.6443 -13.50%
2015 48.8047 44.6122 53.9435 43.4417 52.7656 19.24%
2014 38.4940 38.1135 45.6696 34.2089 44.2524 14.18%
2013 31.4236 23.1324 38.9942 23.1324 38.7552 69.95%
2012 22.9490 23.5454 25.0408 21.5581 22.8036 -3.78%
2011 19.1614 17.0623 23.7337 16.2317 23.7001 39.43%
2010 16.1772 15.8666 17.7217 14.0579 16.9981 8.74%
2009 13.0168 13.9879 15.8725 10.2566 15.6313 14.78%
2008 12.2334 14.4517 14.9771 9.9749 13.6188 -6.05%
2007 15.5321 14.0171 17.4034 13.8684 14.4955 4.75%
2006 12.4704 11.6697 13.8384 10.5220 13.8384 19.93%
2005 11.9532 12.2052 12.9936 10.5600 11.5392 -6.16%
2004 11.8625 13.6086 14.2068 10.6737 12.2964 -7.27%
2003 11.4121 10.6685 13.2609 9.3810 13.2609 29.02%
2002 13.3112 21.6285 21.8199 8.9067 10.2778 -52.36%
2001 24.0713 29.6788 29.6788 20.7274 21.5735 -29.71%
2000 24.0009 26.3107 30.6917 17.8348 30.6917 17.11%
1999 27.6863 26.2795 31.8227 23.3048 26.2086 -2.80%
1998 21.7826 18.8658 26.9647 17.9049 26.9647 42.93%
1997 15.0407 10.4688 19.4202 10.4688 18.8658 77.07%
1996 8.8313 8.0388 11.2360 7.6185 10.6546 32.15%
1995 6.3751 5.3622 8.0858 5.2831 8.0623 53.26%
1994 4.9216 4.9565 5.4408 4.4257 5.2604 6.09%
1993 4.8847 5.4449 5.4449 4.2981 4.9582 -9.48%
1992 5.7375 6.9476 6.9870 4.9940 5.4774 -21.16%
1991 6.1303 5.0865 6.9476 4.6857 6.9476 35.84%
1990 4.4135 4.1797 5.1259 3.7561 5.1147 24.55%
1989 3.5544 3.1252 4.1500 3.0984 4.1064 28.87%
1988 2.9675 3.0123 3.2039 2.6815 3.1864 9.89%
1987 3.3219 2.9381 3.8307 2.5422 2.8995 0.78%
1986 2.6358 2.2897 3.0600 2.1027 2.8772 24.71%
1985 2.0410 1.7848 2.3548 1.7325 2.3071 26.48%
1984 1.6155 1.5020 1.8283 1.4539 1.8241 23.98%
1983 1.3521 1.1666 1.6587 1.0970 1.4713 25.64%
1982 1.0349 0.9185 1.2754 0.8903 1.1710 26.58%
1981 0.9115 0.8880 1.0186 0.8032 0.9251 5.46%
1980 0.7089 0.6335 0.8946 0.5354 0.8772 36.15%
1979 0.6016 0.6202 0.6660 0.5441 0.6443 3.50%
1978 0.5864 0.5812 0.6921 0.4919 0.6225 6.30%
1977 0.5672 0.5920 0.6202 0.5028 0.5856 -1.99%
1976 0.6365 0.6029 0.7204 0.5386 0.5975 -0.35%
1975 0.5406 0.4451 0.6409 0.4102 0.5996 37.40%
1974 0.4045 0.4070 0.4887 0.2753 0.4364 8.10%
1973 0.5324 0.5964 0.6214 0.3831 0.4037 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.960B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.520B 14.16
Vertex Pharmaceuticals (VRTX) United States $101.600B 29.25
Regeneron Pharmaceuticals (REGN) United States $98.916B 23.98
CSL (CSLLY) Australia $85.014B 0.00
Gilead Sciences (GILD) United States $83.333B 9.96
GSK (GSK) United Kingdom $82.069B 10.29
Moderna (MRNA) United States $39.605B 0.00
Biogen (BIIB) United States $27.933B 13.05
Argenex SE (ARGX) Netherlands $21.716B 0.00
BioNTech SE (BNTX) Germany $20.540B 20.97
Genmab (GMAB) Denmark $18.865B 24.18
Illumina (ILMN) United States $18.838B 135.97
Alnylam Pharmaceuticals (ALNY) United States $18.302B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.075B 72.38
BeiGene (BGNE) Cayman Islands $12.611B 0.00
Incyte (INCY) United States $11.837B 19.67
Exact Sciences (EXAS) United States $11.476B 0.00
Sarepta Therapeutics (SRPT) United States $11.070B 0.00
Bio-Techne Corp (TECH) United States $9.861B 36.68
Bio-Rad Laboratories (BIO.B) United States $9.655B 28.76
Repligen (RGEN) United States $8.989B 93.05
QIAGEN (QGEN) Netherlands $8.952B 18.53
Legend Biotech (LEGN) United States $8.883B 0.00
Roivant Sciences (ROIV) United Kingdom $8.413B 0.00
Ascendis Pharma (ASND) Denmark $8.278B 0.00
Intra-Cellular Therapies (ITCI) United States $7.424B 0.00
Viking Therapeutics (VKTX) United States $7.326B 0.00
Cytokinetics (CYTK) United States $7.104B 0.00
Exelixis (EXEL) United States $6.934B 35.73
Vaxcyte (PCVX) United States $6.790B 0.00
Apellis Pharmaceuticals (APLS) United States $5.792B 0.00
Blueprint Medicines (BPMC) United States $5.409B 0.00
Krystal Biotech (KRYS) United States $4.837B 0.00
Halozyme Therapeutics (HALO) United States $4.831B 14.91
CRISPR Therapeutics AG (CRSP) Switzerland $4.716B 0.00
Zealand Pharma (ZLDPF) Denmark $4.469B 0.00
Immunovant (IMVT) United States $4.131B 0.00
Nuvalent (NUVL) United States $4.116B 0.00
Alkermes (ALKS) Ireland $4.062B 21.44
Insmed (INSM) United States $3.889B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.630B 0.00
Biohaven (BHVN) United States $3.593B 0.00
ImmunityBio (IBRX) United States $3.548B 0.00
Axsome Therapeutics (AXSM) United States $3.302B 0.00
Iovance Biotherapeutics (IOVA) United States $3.296B 0.00
Fortrea Holdings (FTRE) United States $3.263B 0.00
SpringWorks Therapeutics (SWTX) United States $3.255B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.140B 0.00
Amicus Therapeutics (FOLD) United States $3.116B 0.00
Apogee Therapeutics (APGE) United States $3.010B 0.00
IDEAYA Biosciences (IDYA) United States $2.995B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.866B 0.00
Arcellx (ACLX) United States $2.854B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.832B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.780B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.719B 0.00
MorphoSys AG (MOR) Germany $2.717B 0.00
Certara (CERT) United States $2.715B 58.45
Janux Therapeutics (JANX) United States $2.478B 0.00
CG Oncology (CGON) United States $2.426B 0.00
Merus (MRUS) Netherlands $2.409B 0.00
Denali Therapeutics (DNLI) United States $2.341B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.312B 0.00
Arvinas (ARVN) United States $2.285B 0.00
Vericel (VCEL) United States $2.238B 0.00
Celldex Therapeutics (CLDX) United States $2.215B 0.00
Vera Therapeutics (VERA) United States $2.179B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.143B 0.00
Keros Therapeutics (KROS) United States $2.133B 0.00
Intellia Therapeutics (NTLA) United States $2.073B 0.00
Kymera Therapeutics (KYMR) United States $2.063B 0.00
Geron (GERN) United States $2.013B 0.00
Guardant Health (GH) United States $1.995B 0.00
Beam Therapeutics (BEAM) United States $1.985B 0.00
Galapagos (GLPG) Belgium $1.926B 0.00
Avidity Biosciences (RNA) United States $1.877B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.876B 0.00
Sana Biotechnology (SANA) United States $1.821B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.762B 0.00
NeoGenomics (NEO) United States $1.746B 0.00
Structure Therapeutics (GPCR) United States $1.727B 0.00
Myriad Genetics (MYGN) United States $1.675B 0.00
Neumora Therapeutics (NMRA) United States $1.664B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.658B 13.77
Twist Bioscience (TWST) United States $1.652B 0.00
Bavarian Nordic (BVNRY) Denmark $1.648B 5.41
Inhibrx (INBX) United States $1.640B 0.00
Dynavax Technologies (DVAX) United States $1.496B 0.00
Akero Therapeutics (AKRO) United States $1.494B 0.00
Protagonist Therapeutics (PTGX) United States $1.490B 0.00
Edgewise Therapeutics (EWTX) United States $1.457B 0.00
Ligand Pharmaceuticals (LGND) United States $1.396B 17.30
Morphic Holding (MORF) United States $1.395B 0.00
ANI Pharmaceuticals (ANIP) United States $1.380B 16.96
ADMA Biologics Inc (ADMA) United States $1.378B 0.00
Kura Oncology (KURA) United States $1.370B 0.00
Zai Lab (ZLAB) China $1.361B 0.00
Gyre Therapeutics (GYRE) United States $1.353B 0.00
Arcus Biosciences (RCUS) United States $1.348B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.325B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.298B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.287B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.197B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.189B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.178B 0.00
AbCellera Biologics (ABCL) Canada $1.148B 0.00
Prothena (PRTA) Ireland $1.128B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.121B 0.00
MannKind (MNKD) United States $1.110B 0.00
Vir Biotechnology (VIR) United States $1.110B 0.00
Scholar Rock Holding (SRRK) United States $1.067B 0.00
Liquidia Technologies (LQDA) United States $1.054B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.043B 0.00
Immunome (IMNM) United States $1.037B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.992B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.981B 0.00
Viridian Therapeutics (VRDN) United States $0.947B 0.00
Belite Bio (BLTE) United States $0.942B 0.00
Abivax SA (ABVX) France $0.936B 0.00
MiMedx (MDXG) United States $0.930B 211.00
Zentalis Pharmaceuticals (ZNTL) United States $0.902B 0.00
Kyverna Therapeutics (KYTX) United States $0.881B 0.00
Immatics (IMTX) Germany $0.866B 0.00
89BIO (ETNB) United States $0.856B 0.00
REGENXBIO (RGNX) United States $0.835B 0.00
ALX Oncology Holdings (ALXO) United States $0.804B 0.00
Tango Therapeutics (TNGX) United States $0.796B 0.00
Pliant Therapeutics (PLRX) United States $0.775B 0.00
Cytek Biosciences (CTKB) United States $0.774B 0.00
Cullinan Oncology (CGEM) United States $0.770B 0.00
CARGO Therapeutics (CRGX) United States $0.768B 0.00
Tyra Biosciences (TYRA) United States $0.759B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.744B 0.00
Disc Medicine (IRON) United States $0.731B 0.00
Cabaletta Bio (CABA) United States $0.731B 0.00
PureTech Health (PRTC) United States $0.727B 0.00
Nurix Therapeutics (NRIX) United States $0.692B 0.00
EnGene Holdings (ENGN) United States $0.686B 0.00
Dianthus Therapeutics (DNTH) United States $0.685B 0.00
Pharming Group (PHAR) Netherlands $0.682B 0.00
Praxis Precision Medicines (PRAX) United States $0.672B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.670B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.661B 0.00
Oric Pharmaceuticals (ORIC) United States $0.658B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.656B 0.00
Aerovate Therapeutics (AVTE) United States $0.627B 0.00
Zymeworks (ZYME) United States $0.625B 0.00
Cogent Biosciences (COGT) United States $0.624B 0.00
HilleVax (HLVX) United States $0.623B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.612B 0.00
Northwest Biotherapeutics (NWBO) United States $0.603B 0.00
Fate Therapeutics (FATE) United States $0.600B 0.00
Olema Pharmaceuticals (OLMA) United States $0.599B 0.00
Absci (ABSI) United States $0.597B 0.00
Mineralys Therapeutics (MLYS) United States $0.596B 0.00
Allogene Therapeutics (ALLO) United States $0.594B 0.00
Prime Medicine (PRME) United States $0.591B 0.00
Nuvation Bio (NUVB) United States $0.587B 0.00
WAVE Life Sciences (WVE) Singapore $0.586B 0.00
Astria Therapeutics (ATXS) United States $0.579B 0.00
CureVac (CVAC) Germany $0.575B 0.00
AnaptysBio (ANAB) United States $0.575B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.574B 0.00
GH Research (GHRS) Ireland $0.572B 0.00
Mesoblast (MESO) Australia $0.572B 0.00
Novavax (NVAX) United States $0.544B 0.00
Stoke Therapeutics (STOK) United States $0.543B 0.00
ArriVent BioPharma (AVBP) United States $0.537B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Celcuity (CELC) United States $0.518B 0.00
Castle Biosciences (CSTL) United States $0.517B 0.00
Applied Therapeutics (APLT) United States $0.511B 0.00
Arbutus Biopharma (ABUS) United States $0.499B 0.00
ACELYRIN, INC (SLRN) United States $0.494B 0.00
Alector (ALEC) United States $0.485B 0.00
Oculis Holding AG (OCS) Switzerland $0.482B 0.00
IGM Biosciences (IGMS) United States $0.478B 0.00
Shattuck Labs (STTK) United States $0.476B 0.00
C4 Therapeutics (CCCC) United States $0.471B 0.00
Editas Medicine (EDIT) United States $0.461B 0.00
Third Harmonic Bio (THRD) United States $0.459B 0.00
Travere Therapeutics (TVTX) United States $0.456B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
Replimune (REPL) United States $0.443B 0.00
Neurogene (NGNE) United States $0.432B 0.00
Mersana Therapeutics (MRSN) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.424B 0.00
Voyager Therapeutics (VYGR) United States $0.420B 2.50
Annexon (ANNX) United States $0.413B 0.00
Biomea Fusion (BMEA) United States $0.413B 0.00
MaxCyte (MXCT) United States $0.411B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.411B 0.00
Entrada Therapeutics (TRDA) United States $0.411B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.399B 0.00
Rani Therapeutics Holdings (RANI) United States $0.394B 0.00
Revance Therapeutics (RVNC) United States $0.392B 0.00
Adlai Nortye (ANL) Cayman Islands $0.389B 0.00
Nkarta (NKTX) United States $0.388B 0.00
ITeos Therapeutics (ITOS) United States $0.383B 0.00
Anika Therapeutics (ANIK) United States $0.381B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
Amarin (AMRN) Ireland $0.377B 0.00
PepGen (PEPG) United States $0.372B 0.00
Humacyte (HUMA) United States $0.372B 0.00
Ocugen (OCGN) United States $0.371B 0.00
Alto Neuroscience (ANRO) United States $0.362B 0.00
Jasper Therapeutics (JSPR) United States $0.359B 0.00
Adaptive Biotechnologies (ADPT) United States $0.354B 0.00
Caribou Biosciences (CRBU) United States $0.353B 0.00
Aura Biosciences (AURA) United States $0.348B 0.00
Tenaya Therapeutics (TNYA) United States $0.338B 0.00
MeiraGTx Holdings (MGTX) United States $0.337B 0.00
Anavex Life Sciences (AVXL) United States $0.334B 0.00
Urogen Pharma (URGN) United States $0.334B 0.00
Precigen (PGEN) United States $0.326B 0.00
TScan Therapeutics (TCRX) United States $0.323B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.322B 0.00
Atea Pharmaceuticals (AVIR) United States $0.312B 0.00
FibroBiologics (FBLG) United States $0.310B 0.00
Ventyx Biosciences (VTYX) United States $0.309B 0.00
Nautilus Biotechnology (NAUT) United States $0.304B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.302B 104.80
ChromaDex (CDXC) United States $0.299B 0.00
CorMedix Inc (CRMD) United States $0.298B 0.00
Invivyd (IVVD) United States $0.296B 0.00
Terns Pharmaceuticals (TERN) United States $0.294B 0.00
Kamada (KMDA) Israel $0.292B 22.09
Monte Rosa Therapeutics (GLUE) United States $0.291B 0.00
Inozyme Pharma (INZY) United States $0.287B 0.00
XOMA (XOMA) United States $0.282B 0.00
Contineum Therapeutics (CTNM) United States $0.281B 0.00
Rapt Therapeutics (RAPT) United States $0.280B 0.00
Erasca (ERAS) United States $0.279B 0.00
Verastem (VSTM) United States $0.274B 0.00
2seventy Bio (TSVT) United States $0.260B 0.00
Inovio Pharmaceuticals (INO) United States $0.259B 0.00
Werewolf Therapeutics (HOWL) United States $0.253B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
Puma Biotechnology (PBYI) United States $0.249B 11.24
XBiotech (XBIT) United States $0.247B 0.00
Coherus BioSciences (CHRS) United States $0.244B 0.00
AC Immune (ACIU) Switzerland $0.239B 0.00
Sutro Biopharma (STRO) United States $0.237B 0.00
Adverum Biotechnologies (ADVM) United States $0.236B 0.00
G1 Therapeutics (GTHX) United States $0.224B 0.00
UniQure (QURE) Netherlands $0.223B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Ovid Therapeutics (OVID) United States $0.220B 0.00
Abeona Therapeutics (ABEO) United States $0.217B 0.00
Skye Bioscience (SKYE) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
Compass Therapeutics (CMPX) United States $0.211B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.208B 0.00
Elevation Oncology (ELEV) United States $0.201B 0.00
Cardiff Oncology (CRDF) United States $0.201B 0.00
X4 Pharmaceuticals (XFOR) United States $0.201B 0.00
Prima BioMed (IMMP) Australia $0.199B 0.00
Opthea (OPT) Australia $0.199B 0.00
Lifecore Biomedical (LFCR) United States $0.198B 0.00
Poseida Therapeutics (PSTX) United States $0.197B 0.00
Innate Pharma S.A (IPHA) France $0.195B 0.00
Scilex Holding (SCLX) United States $0.194B 0.00
Codexis (CDXS) United States $0.194B 0.00
Akoya Biosciences (AKYA) United States $0.192B 0.00
Kodiak Sciences (KOD) United States $0.189B 0.00
Adicet Bio (ACET) United States $0.187B 0.00
Alimera Sciences (ALIM) United States $0.186B 0.00
Gossamer Bio (GOSS) United States $0.185B 0.00
GENFIT S.A (GNFT) France $0.181B 0.00
Trevi Therapeutics (TRVI) United States $0.178B 0.00
23andMe Holding (ME) United States $0.172B 0.00
Inventiva S.A (IVA) France $0.169B 0.00
Greenwich LifeSciences (GLSI) United States $0.168B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.165B 0.00
Compugen (CGEN) Israel $0.165B 0.00
BioStem Technologies (BSEM) $0.162B 0.00
Candel Therapeutics (CADL) United States $0.160B 0.00
ScPharmaceuticals (SCPH) United States $0.159B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.155B 0.00
CervoMed (CRVO) United States $0.154B 0.00
INmune Bio (INMB) United States $0.153B 0.00
Renovaro (RENB) United States $0.148B 0.00
LENZ Therapeutics (LENZ) United States $0.147B 0.00
I-Mab (IMAB) China $0.146B 0.00
Molecular Partners AG (MOLN) Switzerland $0.142B 0.00
Omega Therapeutics (OMGA) United States $0.141B 0.00
Spyre Therapeutics (SYRE) United States $0.139B 0.00
Cellectis S.A (CLLS) France $0.137B 0.00
Syros Pharmaceuticals (SYRS) United States $0.137B 0.00
Zura Bio (ZURA) United States $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.131B 0.00
Rezolute (RZLT) United States $0.130B 0.00
Sagimet Biosciences (SGMT) United States $0.130B 0.00
TELA Bio (TELA) United States $0.127B 0.00
VistaGen Therapeutics (VTGN) United States $0.126B 0.00
BioAtla (BCAB) United States $0.122B 0.00
Coya Therapeutics (COYA) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.120B 0.00
CytomX Therapeutics (CTMX) United States $0.119B 0.00
Repare Therapeutics (RPTX) Canada $0.119B 0.00
Vor Biopharma (VOR) $0.118B 0.00
Agenus (AGEN) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Adagene (ADAG) China $0.112B 0.00
Seer (SEER) United States $0.109B 0.00
Immunic (IMUX) United States $0.109B 0.00
ATyr Pharma (LIFE) United States $0.108B 0.00
Vigil Neuroscience (VIGL) United States $0.108B 0.00
Bluebird Bio (BLUE) United States $0.105B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.101B 0.00
PDS Biotechnology (PDSB) United States $0.100B 0.00
Cartesian Therapeutics (RNAC) United States $0.100B 0.00
Emergent Biosolutions (EBS) United States $0.100B 0.00
BioHarvest Sciences (CNVCF) Canada $0.099B 0.00
Annovis Bio (ANVS) United States $0.099B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Genelux (GNLX) United States $0.097B 0.00
Elicio Therapeutics (ELTX) United States $0.095B 0.00
Seres Therapeutics (MCRB) United States $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Curis (CRIS) United States $0.094B 0.00
Allakos (ALLK) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Sangamo Therapeutics (SGMO) United States $0.092B 0.00
YS Biopharma (YS) China $0.087B 0.00
Alpha Teknova (TKNO) United States $0.086B 0.00
Connect Biopharma Holdings (CNTB) United States $0.085B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Athira Pharma (ATHA) United States $0.081B 0.00
Spero Therapeutics (SPRO) United States $0.081B 3.00
Eton Pharmaceuticals (ETON) United States $0.081B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.080B 0.00
Affimed (AFMD) Germany $0.080B 0.00
Precision BioSciences (DTIL) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.079B 0.00
Cue Biopharma (CUE) United States $0.079B 0.00
BioXcel Therapeutics (BTAI) United States $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Passage Bio (PASG) United States $0.078B 0.00
Q32 Bio (QTTB) United States $0.078B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.077B 0.00
Leap Therapeutics (LPTX) United States $0.077B 0.00
HOOKIPA Pharma (HOOK) United States $0.075B 0.00
InflaRx (IFRX) Germany $0.074B 0.00
Cognition Therapeutics (CGTX) United States $0.074B 0.00
AN2 Therapeutics (ANTX) United States $0.074B 0.00
Elutia (ELUT) United States $0.074B 0.00
Gritstone Bio (GRTS) United States $0.073B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.073B 0.00
BeyondSpring (BYSI) United States $0.072B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Instil Bio (TIL) United States $0.069B 0.00
Landos Biopharma (LABP) United States $0.068B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.067B 0.00
Rallybio (RLYB) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
Cidara Therapeutics (CDTX) United States $0.065B 0.00
Lantern Pharma (LTRN) United States $0.064B 0.00
Celularity (CELU) United States $0.064B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Equillium (EQ) United States $0.063B 0.00
Kronos Bio (KRON) United States $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.062B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.062B 0.00
Ocean Biomedical (OCEA) United States $0.061B 0.00
HCW Biologics (HCWB) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Ikena Oncology (IKNA) United States $0.060B 0.00
Checkpoint Therapeutics (CKPT) United States $0.060B 0.00
Aligos Therapeutics (ALGS) United States $0.060B 0.00
Kezar Life Sciences (KZR) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
AVROBIO (AVRO) United States $0.055B 0.00
Genenta Science S.p.A (GNTA) Italy $0.055B 0.00
Immuneering (IMRX) United States $0.054B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
Vaxxinity (VAXX) United States $0.053B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Apollomics (APLM) United States $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Beyond Air (XAIR) United States $0.046B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Clene (CLNN) United States $0.044B 0.00
Quince Therapeutics (QNCX) United States $0.043B 0.00
Ocuphire Pharma (OCUP) United States $0.043B 0.00
SAB Biotherapeutics (SABS) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
Carmell (CTCX) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
NextCure (NXTC) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
Cara Therapeutics (CARA) United States $0.040B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.039B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Semper Paratus Acquisition (TVGN) United States $0.036B 0.00
Promis Neurosciences (PMN) Canada $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
BioAffinity Technologies (BIAF) United States $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.032B 0.00
Theratechnologies (THTX) Canada $0.032B 0.00
IN8bio (INAB) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Aprea Therapeutics (APRE) United States $0.031B 0.00
Lexaria Bioscience (LEXX) Canada $0.030B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Prenetics Global (PRE) Cayman Islands $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
NKGen Biotech (NKGN) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.022B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Aileron Therapeutics (ALRN) United States $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
Lumos Pharma (LUMO) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Telesis Bio (TBIO) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Longeveron (LGVN) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.36
Kineta (KA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Invo BioScience (INVO) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00